Insider · CIK 0001388547

FARLEY PEGGY A

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001388547

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-04-20	USRMU.S. Stem Cell, Inc.P Purchase	Director, COO & CFO	PPurchase	+77.2K sh	$0.54	+$41.7K	1,597,747
2010-04-20	USRMU.S. Stem Cell, Inc. · Warrant (right to buy)A Award	Director, COO & CFO	AAward	+23.2K sh	—	—	161,256
2010-04-01	USRMU.S. Stem Cell, Inc.P Purchase	Director, COO & CFO	PPurchase	+452K sh	$0.67	+$303K	1,520,517
2010-04-01	USRMU.S. Stem Cell, Inc. · Warrant (right to buy)A Award	Director, COO & CFO	AAward	+136K sh	—	—	138,087
2010-02-26	USRMU.S. Stem Cell, Inc.P Purchase	Director, COO & CFO	PPurchase	+8,000 sh	$0.58	+$4,640	1,068,227
2010-02-26	USRMU.S. Stem Cell, Inc. · Warrant (right to buy)A Award	Director, COO & CFO	AAward	+2,400 sh	—	—	2,400
2010-02-26	USRMU.S. Stem Cell, Inc.P Purchase	Director, COO & CFO	PPurchase	+8,000 sh	$0.58	+$4,640	865,102
2010-02-26	USRMU.S. Stem Cell, Inc. · Warrant (righ to buy)A Award	Director, COO & CFO	AAward	+2,400 sh	—	—	2,400
2010-02-11	USRMU.S. Stem Cell, Inc.X Exercise of In-Money	Director, COO & CFO	XExercise of In-Money	+308K sh	$0.00	+$307.692	857,102
2010-02-11	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)X Exercise of In-Money	Director, COO & CFO	XExercise of In-Money	−308K sh	$0.00	−$307.692	35,000
2010-02-11	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)A Award	Director, COO & CFO	AAward	+40K sh	—	—	75,000
2010-02-11	USRMU.S. Stem Cell, Inc.X Exercise of In-Money	Director, COO & CFO	XExercise of In-Money	+308K sh	$307.69	+$94.7M	857,102
2010-02-11	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)X Exercise of In-Money	Director, COO & CFO	XExercise of In-Money	−308K sh	$307.69	−$94.7M	35,000
2010-02-11	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)A Award	Director, COO & CFO	AAward	+40K sh	—	—	75,000
2010-02-02	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)A Award	Director, COO & CFO	AAward	+308K sh	—	—	342,692
2010-02-02	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)A Award	Director, COO & CFO	AAward	+308K sh	—	—	342,692
2009-03-02	USRMU.S. Stem Cell, Inc.M Exercise/Conversion	Director, COO & CFO	MExercise/Conversion	+40K sh	$0.80	+$32K	40,000
2009-03-02	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, COO & CFO	MExercise/Conversion	−40K sh	—	—	35,000
2009-01-13	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)A Award	Director, COO & CFO	AAward	+40K sh	—	—	75,000
2008-04-18	USRMU.S. Stem Cell, Inc. · Stock Option (right to buy)A Award	Director, COO & CFO	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Apr 304
FARLEY PEGGY A0001388431-10-000017
SEC(opens sec.gov)
Apr 294/A
FARLEY PEGGY A0001388431-10-000016
SEC(opens sec.gov)
Mar 44
FARLEY PEGGY A0001388431-10-000013
SEC(opens sec.gov)
Feb 254/A
FARLEY PEGGY A0001388431-10-000010
SEC(opens sec.gov)
Feb 194
FARLEY PEGGY A0001388431-10-000009
SEC(opens sec.gov)
Mar 44
FARLEY PEGGY A0001388431-09-000010
SEC(opens sec.gov)
Feb 204
FARLEY PEGGY A0001388431-09-000009
SEC(opens sec.gov)
May 194
BIOHEART, INC.0001144204-08-030629
SEC(opens sec.gov)

Companies

U.S. Stem Cell, Inc.Director, COO & CFOUSRM

Address

1160 FIFTH AVENUE SUITE 205

NEW YORK, NY, 10029